Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Chronic glomerular diseases, associated with renal failure and cardiovascular morbidity, represent a major health issue. However, they remain poorly understood. Here we have reported that tightly controlled mTOR activity was crucial to maintaining glomerular podocyte function, while dysregulation of mTOR facilitated glomerular diseases. Genetic deletion of mTOR complex 1 (mTORC1) in mouse podocytes induced proteinuria and progressive glomerulosclerosis. Furthermore, simultaneous deletion of both mTORC1 and mTORC2 from mouse podocytes aggravated the glomerular lesions, revealing the importance of both mTOR complexes for podocyte homeostasis. In contrast, increased mTOR activity accompanied human diabetic nephropathy, characterized by early glomerular hypertrophy and hyperfiltration. Curtailing mTORC1 signaling in mice by genetically reducing mTORC1 copy number in podocytes prevented glomerulosclerosis and significantly ameliorated the progression of glomerular disease in diabetic nephropathy. These results demonstrate the requirement for tightly balanced mTOR activity in podocyte homeostasis and suggest that mTOR inhibition can protect podocytes and prevent progressive diabetic nephropathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Gödel et al. [16] suggested that mTOR signaling plays a role in podocyte homeostasis.”
From A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I (2018) · cites this paper as [16]
In the citing paper
“The decrease in activity of neurofibromin in NF1 might also be associated with LPG which is a glomerular disease, and contribute to the development of LPG as an additional factor.”
From A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I (2018) · cites this paper as [16]
In the citing paper
“Although podocytes have high basal levels of autophagy, high mTORC1 activity is also required for these cells to maintain their function”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [51]
In the citing paper
“However, the side effects of long-term or complete mTORC1 inhibition in kidney cells have been well-recognized, such as the early onset of proteinuria caused by specific inhibition of mTORC1 activity in podocytes in mice and the disruption of kidney tubular homeostasis caused by specific inhibition of mTORC1 activity in kidney tubular cells in mice51,80.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [51]
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Self-citationA global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
The unbiased estimation of number and sizes of arbitrary particles using the disector
Sterio, D. C. (1984) · Journal of Microscopy · doi:10.1111/j.1365-2818.1984.tb02501.x · Cited by 2,519
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Laplante, M., & Sabatini, D. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,170
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Holz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123
A principle for counting tissue structures on random sections
Weibel, E. R., & Gomez, D. M. (1962) · Journal of Applied Physiology · doi:10.1152/jappl.1962.17.2.343 · Cited by 833
Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S. J., Lindenmeyer, M. T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39492 · Cited by 721
Self-citationDrosophila S6 Kinase: A Regulator of Cell Size
Montagne, J., Stewart, M. J., Stocker, H., Hafen, E., Kozma, S. C., & Thomas, G. (1999) · Science · doi:10.1126/science.285.5436.2126 · Cited by 717
Bentzinger, C. F., Romanino, K., Cloëtta, D., Lin, S., Mascarenhas, J. B., Oliveri, F., Xia, J., Casanova, E., Costa, C. F., Brink, M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.002 · Cited by 640
Self-citationRegulation of cellular growth by the Drosophila target of rapamycin dTOR
Zhang, H., Stallock, J. P., Ng, J. C., Reinhard, C., & Neufeld, T. P. (2000) · Genes & Development · doi:10.1101/gad.835000 · Cited by 624
mTOR Is Essential for Growth and Proliferation in Early Mouse Embryos and Embryonic Stem Cells
Murakami, M., Ichisaka, T., Maeda, M., Oshiro, N., Hara, K., Edenhofer, F., Kiyama, H., Yonezawa, K., & Yamanaka, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6710-6718.2004 · Cited by 624
mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Rüegg, M. A., Hall, M. N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44771 · Cited by 538
Self-citationThe mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M., & Sonenberg, N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601166 · Cited by 531
A New Method for Large Scale Isolation of Kidney Glomeruli from Mice
Takemoto, M., Asker, N., Gerhardt, H., Lundkvist, A., Johansson, B. R., Saito, Y., & Betsholtz, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64239-3 · Cited by 516
Gangloff, Y.-G., Mueller, M., Dann, S. G., Svoboda, P., Sticker, M., Spetz, J.-F., Um, S. H., Brown, E. J., Cereghini, S., Thomas, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9508-9516.2004 · Cited by 485
Adipose-Specific Knockout of raptor Results in Lean Mice with Enhanced Mitochondrial Respiration
Polak, P., Cybulski, N., Feige, J. N., Auwerx, J., Rüegg, M. A., & Hall, M. N. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.003 · Cited by 480
Self-citationInsulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
Welsh, G. I., Hale, L. J., Eremina, V., Jeansson, M., Maezawa, Y., Lennon, R., Pons, D. A., Owen, R. J., Satchell, S. C., Miles, M. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.08.015 · Cited by 462
Self-citationThe Notch pathway in podocytes plays a role in the development of glomerular disease
Niranjan, T., Bielesz, B., Gruenwald, A., Ponda, M. P., Kopp, J. B., Thomas, D. B., & Susztak, K. (2008) · Nature Medicine · doi:10.1038/nm1731 · Cited by 427
Wiggins, J. E., Goyal, M., Sanden, S. K., Wharram, B. L., Shedden, K. A., Misek, D. E., Kuick, R. D., & Wiggins, R. C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050488 · Cited by 350
Bielesz, B., Sirin, Y., Si, H., Niranjan, T., Gruenwald, A., Ahn, S., Kato, H., Pullman, J., Gessler, M., Haase, V. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43025 · Cited by 345
Podocyte‐specific expression of cre recombinase in transgenic mice
Moeller, M. J., Sanden, S. K., Soofi, A., Wiggins, R. C., & Holzman, L. B. (2003) · genesis · doi:10.1002/gene.10164 · Cited by 333
Berthier, C. C., Zhang, H., Schin, M., Henger, A., Nelson, R. G., Yee, B., Boucherot, A., Neusser, M. A., Cohen, C. D., Carter-Su, C., et al. (2009) · Diabetes · doi:10.2337/db08-1328 · Cited by 317
Self-citationmTOR and the control of whole body metabolism
Polak, P., & Hall, M. N. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.024 · Cited by 306
Self-citationThe Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Lieberthal, W., & Levine, J. S. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111186 · Cited by 280
Cohen, C. D., Frach, K., Schlöndorff, D., & Kretzler, M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00113.x · Cited by 264
Self-citationTuberous sclerosis complex proteins control axon formation
Choi, Y.-J., Di Nardo, A., Kramvis, I., Meikle, L., Kwiatkowski, D. J., Sahin, M., & He, X. (2008) · Genes & Development · doi:10.1101/gad.1685008 · Cited by 258
Glomerular size and structure in diabetes mellitus. II. Late abnormalities
Gundersen, H. J. G., & �sterby, R. (1977) · Diabetologia · doi:10.1007/bf00996326 · Cited by 256
Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats
Lloberas, N., Cruzado, J. M., Franquesa, M., Herrero-Fresneda, I., Torras, J., Alperovich, G., Rama, I., Vidal, A., & Grinyó, J. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050549 · Cited by 245
Glomerular size and structure in diabetes mellitus: III. Early enlargement of the capillary surface
Kroustrup, J. P., Gundersen, H. J. G., & �sterby, R. (1977) · Diabetologia · doi:10.1007/bf01219701 · Cited by 214
High Sirolimus Levels May Induce Focal Segmental Glomerulosclerosis De Novo
Letavernier, E., Bruneval, P., Mandet, C., Van Huyen, J.-P. D., Pe[Combining Acute Accent]raldi, M.-N. D., Helal, I., Noe[Combining Diaeresis]l, L.-H. A. A. G. A., & Legendre, C. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03751106 · Cited by 200
Glomerular size and structure in diabetes mellitus: I. Early abnormalities
�sterby, R., & Gundersen, H. J. G. (1975) · Diabetologia · doi:10.1007/bf00422326 · Cited by 167
Mori, H., Inoki, K., Masutani, K., Wakabayashi, Y., Komai, K., Nakagawa, R., Guan, K.-L., & Yoshimura, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.136 · Cited by 165
Self-citationInhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice
Sakaguchi, M., Isono, M., Isshiki, K., Sugimoto, T., Koya, D., & Kashiwagi, A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.012 · Cited by 164
Role of growth hormone in the development of experimental renal scarring
Nahas, A. M. E., Bassett, A. H., Cope, G. H., & Carpentier, J. E. L. (1991) · Kidney International · doi:10.1038/ki.1991.175 · Cited by 155
Cohen, C. D., Klingenhoff, A., Boucherot, A., Nitsche, A., Henger, A., Brunner, B., Schmid, H., Merkle, M., Saleem, M. A., Koller, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511257103 · Cited by 134
Self-citationPost-Transplantation Proteinuria and Sirolimus
Izzedine, H., Brocheriou, I., & Frances, C. (2005) · New England Journal of Medicine · doi:10.1056/nejm200511103531922 · Cited by 110
Determinants of Glomerular Volume in Different Cortical Zones of the Human Kidney
Samuel, T., Hoy, W. E., Douglas-Denton, R. N., Hughson, M. D., & Bertram, J. F. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010123 · Cited by 109
Significance and Management of Proteinuria in Kidney Transplant Recipients
Amer, H., & Cosio, F. G. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008091005 · Cited by 107
Heparan Sulfate of Perlecan Is Involved in Glomerular Filtration
Morita, H., Yoshimura, A., Inui, K., Ideura, T., Watanabe, H., Wang, L., Soininen, R., & Tryggvason, K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050387 · Cited by 105
Nck Proteins Maintain the Adult Glomerular Filtration Barrier
Jones, N., New, L. A., Fortino, M. A., Eremina, V., Ruston, J., Blasutig, I. M., Aoudjit, L., Zou, Y., Liu, X., Yu, G.-L., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009010056 · Cited by 97
Meier, M., Park, J.-K., Overheu, D., Kirsch, T., Lindschau, C., Gueler, F., Leitges, M., Menne, J., & Haller, H. (2007) · Diabetes · doi:10.2337/db06-0891 · Cited by 96
The story of Notch and chronic kidney disease
Sharma, S., Sirin, Y., & Suszták, K. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283414c88 · Cited by 87
Cohen, C. D., Lindenmeyer, M. T., Eichinger, F., Hahn, A., Seifert, M., Moll, A. G., Schmid, H., Kiss, E., Gröne, E., Gröne, H.-J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002937 · Cited by 77
Self-citationRole of TSC–mTOR pathway in diabetic nephropathy
Inoki, K. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.028 · Cited by 73
Self-citationHerbach, N., Schairer, I., Blutke, A., Kautz, S., Siebert, A., Göke, B., Wolf, E., & Wanke, R. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90665.2008 · Cited by 69
Self-citationTorras, J., Herrero-Fresneda, I., Gulias, O., Flaquer, M., Vidal, A., Cruzado, J. M., Lloberas, N., Franquesa, M. {. D. }., & Grinyo, J. M. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp367 · Cited by 65
The pathophysiology of protein-overload proteinuria.
Weening, J. J., van Guldener, C., Daha, M. R., Klar‐Mohamad, N., van der Wal, A., & Prins, F. A. (1987) · PubMed Central · Cited by 51
Hoeflich, A., Weber, M. M., Fisch, T., Nedbal, S., Fottner, C., Elmlinger, M. W., Wanke, R., & Wolf, E. (2002) · The FASEB Journal · doi:10.1096/fj.02-0349com · Cited by 49
Self-citationRole of Podocytes in Focal Sclerosis: Defining the Point of No Return
Kretzler, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080841 · Cited by 48
Self-citationDiabetic nephropathy: pathogenesis, diagnosis, and prevention of progression.
Estacio, R. O., & Schrier, R. W. (2001) · PubMed · Cited by 42
Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis
Rangan, G. K., & Coombes, J. D. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm191 · Cited by 41
Munivenkatappa, R. B., Haririan, A., Jc, P., Cb, D., Dinits-Pensy, M. Y., & Klassen, D. K. (2010) · PubMed · doi:10.14670/hh-25.189 · Cited by 26
Large juxtamedullary glomeruli and afferent arterioles in healthy primates
Skov, K., Nyengaard, J. R., Patwardan, A., & Mulvany, M. J. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00398.x · Cited by 26
Stereological estimates of volume-weighted mean glomerular volume in streptozotocin-diabetic rats.
Artacho‐Pérula, E., Roldán-Villalobos, R., Salcedo-Leal, I., & Vaamonde-Lemos, R. (1993) · PubMed · Cited by 26
The sizes of renal glomeruli in fetuses and infants.
Souster, L. P., & Emery, J. L. (1980) · PubMed · Cited by 22
Research works printed but not linked: 5
- Estacio, 2001, Adv Intern Med., 46, 359
- Munivenkatappa, 2010, Histol Histopathol., 25, 189
- Weening, 1987, Am J Pathol., 129, 64
- Artacho-Perula, 1993, Lab Invest., 68, 56
- Souster, 1980, J Anat., 130, 595
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
“Furthermore, recent studies have shown that either deletion or upregulation of components of the mTOR pathway, including the mTOR complexes mTORC1 and mTOR2 (210, 267), contribute to the development of diabetic nephropathy.”
BackgroundThomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Shimano, H., & Sato, R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.91 · Cited by 1,174
Rapamycin passes the torch: a new generation of mTOR inhibitors
Benjamin, D., Colombi, M., Moroni, C., & Hall, M. N. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3531 · Cited by 989
Self-citationMolecular mechanisms of diabetic kidney disease
Reidy, K., Kang, H. M., Hostetter, T., & Susztak, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72271 · Cited by 909
“Decreased activation of mTORC1 protected against DKD in mouse models (77, 78), but complete deletion of mTOR caused glomerular disease (78).”
Metadata
- Authors
- Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., Debreczeni-Mór, A., Lindenmeyer, M. T., Rastaldi, M.-P., Hartleben, G., Wiech, T., Fornoni, A., Nelson, R. G., Kretzler, M., Wanke, R., Pavenstädt, H., Kerjaschki, D., Cohen, C. D., Hall, M. N., Rüegg, M. A., Inoki, K., Walz, G., & Huber, T. B.
- Affiliations
- University of Freiburg (DE)
- Ludwig-Maximilians-Universität München (DE)
- University of Zurich (CH)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
- University of Miami (US)
- National Institutes of Health (US)
- University of Münster (DE)
- Medical University of Vienna (AT)
- University of Basel (CH)
- Life Sciences Institute (SG)
- Corresponding author
- Huber, Tobias B.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-06-01
- Volume
- 121
- Issue
- 6
- Pages
- 2197-2209
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3104746
- OpenAlex
- W2051719011
- Cited by
- 547
- References
- 62
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 28 · 2023: 36 · 2022: 30 · 2021: 43 · 2020: 50 · 2019: 39 · 2018: 40 · 2017: 34 · 2016: 38 · 2015: 36 · 2014: 40 · 2013: 47 · 2012: 25
- FWCI
- 31.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (122439)
- National Institutes of Health (5r01dk083491-09)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK083491, P30DK081943, DK-083491, R01DK124709)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- mTOR, mTORC1, mTORC2, podocytes, diabetic nephropathy, glomerulosclerosis, proteinuria, glomerular hypertrophy, hyperfiltration, mTOR inhibition, glomerular disease, gene deletion
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Regulatory-Associated Protein of mTOR, Rapamycin-Insensitive Companion of mTOR Protein, Adult, Animals, Carrier Proteins, Diabetes Mellitus, Experimental, Diabetic Nephropathies, Humans, Kidney Glomerulus, Mice, Inbred C57BL, Mice, Inbred ICR, Mice, Transgenic, Nephrosis, Lipoid, Proteins, Proteinuria, Transcription Factors, Trans-Activators, Mice, Knockout, Disease Progression, Gene Dosage, Genetic Predisposition to Disease, Sirolimus, Multiprotein Complexes, Adaptor Proteins, Signal Transducing, Podocytes, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.